Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Constellium SENYSE: CSTM
Operating Income · Q3 FY2026 · quarter ended Sep 2026
Operating income grows 40.6% year over year
Q3 FY2026 operating income of $187M rose 40.6% year over year. Sequentially, it rose 70.0% from the prior quarter. Over 3 fiscal years it compounded at +14.1% a year.
Context
- Operating income amounted to 5.6% of revenue in FY2025, up 1.9 pp from a year earlier.
- Operating income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 4 analysts of $492.76M (+4.0%) for the fiscal year ending Dec 2026, a slowdown from the +80.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $187M+70.0% QoQ
- Last fiscal yearDec 2025
- $474M+80.5% YoY
- LTMSep 2026
- $693M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +40.6% | -27.1% | -67.7 pp |
| 1 year | +80.5% | +4.0% | -76.5 pp |
| 3-year CAGR | +14.1% | +1.1% | -13.1 pp |
| 5-year CAGR | +0.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
Mixed currencies · from the income statement
- Latest · FY2025
- 474M USD
- Year-over-year change
- —
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 474M | — |
| FY2024 | 2024-12-31 | 262.67M | -25.1% |
| FY2023 | 2023-12-31 | 350.76M | +10.0% |
| FY2022 | 2022-12-31 | 318.74M | -41.8% |
| FY2021 | 2021-12-31 | 547.99M | — |
Operating Income vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
- Operating income amounts to 6.9% of revenue for CSTM, versus a peer median of 9.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 5.46B ZAR | +496.1% | +56.6% | 50.9% | |
| LTM Mar 2026 | R$4.7B BRL | -8.5% | -19.3% | 10.6% | |
| LTM Sep 2026 | $693M USD | — | +14.1% | 6.9% | |
| LTM Sep 2026 | $630.7M USD | +261.6% | — | 21.0% | |
| LTM Jun 2026 | $621.32M USD | +106.4% | — | 52.5% | |
| LTM Jun 2026 | $378.1M USD | +114.9% | +28.4% | 36.1% | |
| LTM Jun 2026 | $340.9M USD | +186.7% | +262.6% | 8.2% | |
| LTM Sep 2026 | $189.53M USD | -26.6% | -46.3% | 2.9% | |
| LTM Jun 2026 | $135M USD | +51.7% | — | 7.3% | |
| LTM Jul 2026 | $130.17M USD | +119.2% | -1.1% | 6.2% | |
| LTM Jun 2026 | -$94.1M USD | -166.4% | -60.1% | 1.4% | |
| Peer median (excluding CSTM) | — | +110.6% | -1.1% | 9.4% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 6.97B | 7.93B | 7.11B | 7.08B | 8.45B |
| Cost of Revenue | 6.21B | 7.03B | 6.15B | 6.18B | 7.59B |
| Gross Profit | 751.79M | 894.89M | 958.68M | 905.83M | 857M |
| Gross Margin | 10.8% | 11.3% | 13.5% | 12.8% | 10.1% |
| Research & Development | 44.16M | 42.75M | 47.25M | 47.32M | 51M |
| Selling, General & Admin | 292.11M | 263.91M | 288.06M | 302.26M | 332M |
| Operating Expenses | 203.8M | 576.15M | 607.92M | 643.16M | 383M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| EBITDA | 802.74M | 518.39M | 583.12M | 523.41M | 852M |
| EBITDA Margin | 11.5% | 6.5% | 8.2% | 7.4% | 10.1% |
| Operating Income | 547.99M | 318.74M | 350.76M | 262.67M | 474M |
| Operating Margin | 7.9% | 4.0% | 4.9% | 3.7% | 5.6% |
| Interest Income | 0 | 0 | 16M | 0 | 0 |
| Interest Expense | 154.84M | 126.12M | 115M | 112M | 114M |
| Other Income / Expenses | (189.08M) | (179.35M) | (139.94M) | (132.3M) | (66M) |
| Income Before Tax | 358.91M | 139.39M | 210.82M | 130.37M | 408M |
| Pre-Tax Margin | 5.2% | 1.8% | 3.0% | 1.8% | 4.8% |
| Income Tax Expense | 62.27M | (153.33M) | 68.15M | 72.43M | 133M |
| Net Income | 290.98M | 286.22M | 138.12M | 54.08M | 273M |
| Net Margin | 4.2% | 3.6% | 1.9% | 0.8% | 3.2% |
| EPS (Basic) | 1.82 | 2.00 | 0.84 | 0.37 | 1.95 |
| EPS (Diluted) | 1.75 | 1.96 | 0.84 | 0.37 | 1.92 |
| Weighted Avg Shares | 141M | 143.63M | 148.81M | 145.49M | 139.68M |
| Weighted Avg Shares (Diluted) | 147.17M | 146.61M | 149.24M | 147.44M | 141.94M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.